Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

SULPHAPHENAZOLE-INDUCED HYPOGLYCAEMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS.

CHRISTENSEN LK, HANSEN JM, KRISTENSEN M.

Lancet. 1963 Dec 21;2(7321):1298-301. No abstract available.

PMID:
14071924
2.

Kinetics of carboxytolbutamide excretion following tolbutamide and carboxytolbutamide administration.

NELSON E, O'REILLY I.

J Pharmacol Exp Ther. 1961 Apr;132:103-9. No abstract available.

PMID:
13728274
3.

Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers.

Williamson KM, Patterson JH, McQueen RH, Adams KF Jr, Pieper JA.

Clin Pharmacol Ther. 1998 Mar;63(3):316-23.

PMID:
9542475
4.

Genetic analysis of CYP2C9 polymorphism in a Japanese population.

Nasu K, Kubota T, Ishizaki T.

Pharmacogenetics. 1997 Oct;7(5):405-9. No abstract available.

PMID:
9352578
5.

Lung cancer risk in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles County.

London SJ, Sullivan-Klose T, Daly AK, Idle JR.

Pharmacogenetics. 1997 Oct;7(5):401-4. No abstract available.

PMID:
9352577
6.

Genetic association between sensitivity to warfarin and expression of CYP2C9*3.

Steward DJ, Haining RL, Henne KR, Davis G, Rushmore TH, Trager WF, Rettie AE.

Pharmacogenetics. 1997 Oct;7(5):361-7.

PMID:
9352571
7.

Human cytochromes mediating N-demethylation of fluoxetine in vitro.

von Moltke LL, Greenblatt DJ, Duan SX, Schmider J, Wright CE, Harmatz JS, Shader RI.

Psychopharmacology (Berl). 1997 Aug;132(4):402-7.

PMID:
9298519
8.

Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C.

Hamman MA, Thompson GA, Hall SD.

Biochem Pharmacol. 1997 Jul 1;54(1):33-41.

PMID:
9296349
9.
10.
11.

Cytochromes P450 mediating the N-demethylation of amitriptyline.

Ghahramani P, Ellis SW, Lennard MS, Ramsay LE, Tucker GT.

Br J Clin Pharmacol. 1997 Feb;43(2):137-44.

12.

Allelic and functional variability of cytochrome P4502C9.

Bhasker CR, Miners JO, Coulter S, Birkett DJ.

Pharmacogenetics. 1997 Feb;7(1):51-8.

PMID:
9110362
13.

Contribution of human cytochrome P450 to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol metabolism, as predicted from heterologous expression in yeast.

Gautier JC, Lecoeur S, Cosme J, Perret A, Urban P, Beaune P, Pompon D.

Pharmacogenetics. 1996 Dec;6(6):489-99.

PMID:
9014198
14.

Identification of cytochromes P450 involved in the human liver microsomal metabolism of the thromboxane A2 inhibitor seratrodast (ABT-001).

Kumar GN, Dubberke E, Rodrigues AD, Roberts E, Dennisen JF.

Drug Metab Dispos. 1997 Jan;25(1):110-5.

15.

Genetic analysis of the human cytochrome P450 CYP2C9 locus.

Stubbins MJ, Harries LW, Smith G, Tarbit MH, Wolf CR.

Pharmacogenetics. 1996 Oct;6(5):429-39.

PMID:
8946475
16.

The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism.

Sullivan-Klose TH, Ghanayem BI, Bell DA, Zhang ZY, Kaminsky LS, Shenfield GM, Miners JO, Birkett DJ, Goldstein JA.

Pharmacogenetics. 1996 Aug;6(4):341-9.

PMID:
8873220
17.

Metabolism of aceclofenac in humans.

Bort R, Ponsoda X, Carrasco E, Gómez-Lechón MJ, Castell JV.

Drug Metab Dispos. 1996 Aug;24(8):834-41.

PMID:
8869816
18.

Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic O-demethylation of R- and S-naproxen.

Miners JO, Coulter S, Tukey RH, Veronese ME, Birkett DJ.

Biochem Pharmacol. 1996 Apr 26;51(8):1003-8.

PMID:
8866821
19.

Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam.

Bonnabry P, Leemann T, Dayer P.

Eur J Clin Pharmacol. 1996;49(4):305-8.

PMID:
8857077
20.

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW.

Pharmacogenetics. 1996 Feb;6(1):1-42. Review.

PMID:
8845856

Supplemental Content

Support Center